PAC09 - List of Authors (Pedersen, C.G.)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pedersen, C.G.

Paper	Title	Page
TU6PFP013	Status of the Siemens Particle Therapy Accelerators	1321
	H. Rohdjess, S. Emhofer, P. Fischer, V.L. Lazarev, M. Leghissa, B. Steiner, E. Tanke, P. Urschütz Siemens Med, Erlangen T. Andersen, A. Baurichter, M. Budde, F. Bødker, B.J. Franczak, I. Jensen, S.P. Møller, C.G. Pedersen, T.B. Sørensen, S.V. Weber, N. Zangenberg Siemens DK, Jyllinge
	Siemens has earned two contracts to deliver Particle Therapy* systems to be operated in Marburg and Kiel, both in Germany. The accelerator consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams can be slowly extracted and delivered to a choice of fixed-angle horizontal, semi-vertical and vertical beam-ports. An overview of the design will be given. At the time of PAC09 installation of the first system will be nearing completion and commissioning will have started. Performance of some of the components and the status of the projects will be presented. *Particle Therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.

Paper

Title

Page

TU6PFP013

Status of the Siemens Particle Therapy Accelerators

1321

H. Rohdjess, S. Emhofer, P. Fischer, V.L. Lazarev, M. Leghissa, B. Steiner, E. Tanke, P. Urschütz
Siemens Med, Erlangen
T. Andersen, A. Baurichter, M. Budde, F. Bødker, B.J. Franczak, I. Jensen, S.P. Møller, C.G. Pedersen, T.B. Sørensen, S.V. Weber, N. Zangenberg
Siemens DK, Jyllinge

Siemens has earned two contracts to deliver Particle Therapy* systems to be operated in Marburg and Kiel, both in Germany. The accelerator consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams can be slowly extracted and delivered to a choice of fixed-angle horizontal, semi-vertical and vertical beam-ports. An overview of the design will be given. At the time of PAC09 installation of the first system will be nearing completion and commissioning will have started. Performance of some of the components and the status of the projects will be presented.

*Particle Therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.